Three years ago the international medical publishing industry created waves by making it mandatory for all Clinical trials to be registered in a public registry before the results or study findings can be published.
International Committee of Medical Journal Editors (ICMJE) has stated that they would publish any papers connected with clinical trials only if the trials have been registered. The current size of the editor group is 11 editors, and this is expected to scale up.
The logic is stated as “missing out on the chance of publishing favorable findings in prestigious journals by not complying with this policy is undesirable for the industry”. This is true for multi-center trials, since industry would want to pitch using the data from these studies. Now that still leaves out early clinical studies, which are known to be potentially dangerous and fraught with huge patient safety issues.
The number of trials registered thus far with the Clinical Trial Registry India is 34, which on a rough guess would be 1-5% of ongoing clinical studies in India.
May be it is more prudent to require that all studies obtaining ethical approval are registered with a public database, at least that covers a larger chunk...
No comments:
Post a Comment